Grail (NASDAQ:GRAL) Shares Down 4.4% – Time to Sell?

Grail, Inc. (NASDAQ:GRAL)’s stock price was down 4.4% during mid-day trading on Thursday . The stock traded as low as $16.78 and last traded at $16.80. Approximately 206,992 shares traded hands during mid-day trading, a decline of 68% from the average daily volume of 640,543 shares. The stock had previously closed at $17.58.

Analyst Ratings Changes

A number of brokerages have recently commented on GRAL. Morgan Stanley started coverage on Grail in a research report on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 price objective for the company. Guggenheim began coverage on Grail in a report on Thursday, October 17th. They set a “neutral” rating on the stock. Finally, Wolfe Research initiated coverage on shares of Grail in a research report on Friday, November 15th. They issued a “peer perform” rating for the company.

Grail Stock Down 1.7 %

The firm has a 50-day moving average price of $18.21.

Insiders Place Their Bets

In other news, CFO Aaron Freidin sold 30,452 shares of the company’s stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $14.02, for a total value of $426,937.04. Following the sale, the chief financial officer now owns 268,277 shares in the company, valued at approximately $3,761,243.54. This represents a 10.19 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Institutional Trading of Grail

Institutional investors and hedge funds have recently bought and sold shares of the company. FNY Investment Advisers LLC bought a new position in Grail during the fourth quarter worth $26,000. B & T Capital Management DBA Alpha Capital Management bought a new position in shares of Grail in the 4th quarter worth about $387,000. A. D. Beadell Investment Counsel Inc. acquired a new position in shares of Grail in the 4th quarter valued at about $430,000. 180 Wealth Advisors LLC acquired a new stake in Grail during the fourth quarter worth about $1,681,000. Finally, Douglas Lane & Associates LLC bought a new position in shares of Grail during the fourth quarter valued at approximately $3,034,000.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.